2001
DOI: 10.1074/jbc.m010896200
|View full text |Cite
|
Sign up to set email alerts
|

The Yeast ALG11 Gene Specifies Addition of the Terminal α1,2-Man to the Man5GlcNAc2-PP-dolicholN-Glycosylation Intermediate Formed on the Cytosolic Side of the Endoplasmic Reticulum

Abstract: The initial steps in N-linked glycosylation involve the synthesis of a lipid-linked core oligosaccharide followed by the transfer of the core glycan to nascent polypeptides in the endoplasmic reticulum (ER). Here, we describe alg11, a new yeast glycosylation mutant that is defective in the last step of the synthesis of the Man 5 GlcNAc 2 -PP-dolichol core oligosaccharide on the cytosolic face of the ER. A deletion of the ALG11 gene leads to poor growth and temperature-sensitive lethality. In an alg11 lesion, b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
65
0

Year Published

2001
2001
2014
2014

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 68 publications
(67 citation statements)
references
References 71 publications
2
65
0
Order By: Relevance
“…The yeast alg11 mutant cannot convert M3-to M5-DLO, but is able to elaborate M3-DLO to iM7-DLO in the ER lumen through the action of Man-P-dolichol-dependent glycosyltransferases (30). This indicates that M3-DLO is a substrate for the flippase in vivo.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The yeast alg11 mutant cannot convert M3-to M5-DLO, but is able to elaborate M3-DLO to iM7-DLO in the ER lumen through the action of Man-P-dolichol-dependent glycosyltransferases (30). This indicates that M3-DLO is a substrate for the flippase in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…This indicates that M3-DLO is a substrate for the flippase in vivo. Even though iM7-DLO is used as an oligosaccharide donor by OST, ⌬alg11 cells under-glycosylate proteins and display a severe growth defect (16,30). This phenotype has been attributed to inefficient flipping of M3-DLO, resulting in a reduced rate of iM7-DLO production and inadequate synthesis of glycoproteins.…”
Section: Discussionmentioning
confidence: 99%
“…The budding yeast S. cerevisiae mannosyltransferase IV/V gene disruptant (ALG11Δ strain JCY20-1c: ura3-52 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ9 leu2-3, 112 alg11Δ::URA3) (ALG11Δ) 16) was kindly provided by Prof. Neta Dean (State University of New York at Stonybrook). In most cases, ALG11Δ was grown in YPDA medium (polypeptone 20 g, yeast extract 10 g, glucose 20 g, and adenine sulfate 0.02 g in 1 L of double distilled water) supplemented with 0.5 M KCl (0.5 M KCl-YPDA) at 26°C, and grown on an agar plate containing 2% agar at 26°C.…”
Section: Methodsmentioning
confidence: 99%
“…We isolated human genes encoding GDP-Man-dependent mannosyltransferases (mannosyltransferase I-V), such as human mannosyltransferase-I (hALG1), 17) III (hALG2), 18) and V (hALG11) (data not shown), which are homologous to S. cerevisiae ALG1, 19) ALG2, 20) and ALG11, 16) respectively, by tBLASTn search. However, as the genes of mannosyltransferase II and IV had not been identified at that time, we tried to isolate the human mannosyltransferase IV gene.…”
Section: )mentioning
confidence: 99%
“…This strategy stops LLO synthesis already during the cytoplasmic steps creating the Man3GlcNAc2. Deletion of alg11 precludes the formation of the A-branch of the LLO, which leads to a very strong hypoglycosylation [18]. In addition to the reduced transfer efficiency, inefficient flipping of the LLO into the ER lumen contributes to the hypoglycosylation phenotype observed in the Δalg11 strain.…”
Section: Modification Of the Llo-biosynthesis And Its Effects On N-glmentioning
confidence: 99%